FDA Approves Teal Wand as First At-Home Cervical Cancer Screening
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
From - Diagnostic Testing & Emerging Technologies
Tumor markers alone may be adequate to monitor for relapse among children and teens with malignant germ cell tumors (MGCTs), according to a study published…
From - Diagnostic Testing & Emerging Technologies
Point-of-care (POC) HbA1c measurements show a high level of agreement with central laboratory test in the outpatient setting…
From - Diagnostic Testing & Emerging Technologies
Given we are still in the midst of cold and flu season, a new study highlights the benefit of point-of-care (POC) polymerase chain reaction (PCR) testing among…
From - Diagnostic Testing & Emerging Technologies
A substantial percentage of patients with type 2 diabetes may be inappropriately self-monitoring blood glucose, according to a research letter published…